Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Affordable Care Act Latest in Half-Century of Healthcare Reform

Bryn Nelson, PhD  |  January 1, 2014

Highlights in 50-year timeline of national healthcare legislation, proposals, and policies since the Social Security Act was adopted in 1965

What the Affordable Care Act Means for Rheumatology

Bryn Nelson, PhD  |  January 1, 2014

Expected to flood the healthcare system with an influx of insured patients, Obamacare will likely exacerbate physician shortages, worsen capacity issues for many rheumatologists, and pressure providers to deliver a measurable quality of care, but analysts say rheumatology patients will benefit from expanded insurance coverage options

Is It Time to Reevaluate Your Physician Compensation Model?

Steven M. Harris, Esq.  |  December 1, 2013

Ongoing payment reform, healthcare consolidation forces rheumatology practices to reconsider ways doctors are paid

2013 ACR/ARHP Annual Meeting: The Rheumatoid Arthritis Treatment Debate

Mary Beth Nierengarten  |  December 1, 2013

Discussion by rheumatologists on the merits of biologics vs. triple therapy for patients with RA lends insight into therapeutic alternatives

2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review

Mary Beth Nierengarten  |  December 1, 2013

Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology

2013 ACR/ARHP Annual Meeting: Advances in Genomic Research Demystify, Defeat Disease

Susan Bernstein  |  December 1, 2013

Researcher J. Craig Venter, PhD, explains how technological progress in metabiomics may enable scientists to create synthetic, engineered bacteria to counter diseases and manufacture virus-fighting vaccines where they are needed

Time Is Right to Join RheumPAC

James Engelbrecht, MD  |  December 1, 2013

We need your help building relationships with Congressional leaders to advance patient care, support research, and promote value of rheumatology

Rheumatology Research Foundation Grant Aids Investigations Into Rheumatoid Arthritis

Staff  |  December 1, 2013

Funds help scientists explore role of neutrophil extracellular traps in the pathogenesis of RA

President’s Perspective: ACR Addresses Reform of Sustainable Growth Rate Formula

Joseph Flood, MD  |  December 1, 2013

The College’s multi-pronged plan to replace flawed SGR payment system requires continued support from rheumatologists, healthcare professionals

Genetic Link Between Cellular Cholesterol Homeostasis and Energy Metabolism

Lara C. Pullen, PhD  |  November 19, 2013

A new study suggests that GATM may serve as the functional link between the ability of statins to lower cholesterol and their ability to cause statin-induced myopathy.   (posted Nov. 19)

  • « Previous Page
  • 1
  • …
  • 235
  • 236
  • 237
  • 238
  • 239
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences